Cover Image

Novel Esomeprazole Magnesium-Loaded Dual-Release Mini-Tablet Polycap: Formulation, Optimization, Characterization, and In Vivo Evaluation in Beagle Dogs

Esomeprazole magnesium (EMP) is a proton pump inhibitor (PPI) that reduces acid secretion. EMP has a short plasma half-life (approximately 1.3 h); hence, nocturnal acid breakthrough (NAB) frequently occurs, disturbing the patient's nighttime comfort and sleep. We aimed to develop a novel esomep...

Full description

Saved in:

Bibliographic Details
Main Authors:	Taek Kwan Kwon (Author), Ji-Hyun Kang (Author), Sang-Beom Na (Author), Jae Ho Kim (Author), Yong-Il Kim (Author), Dong-Wook Kim (Author), Chun-Woong Park (Author)
Format:	Book
Published:	MDPI AG, 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enhanced Bioavailability of Tadalafil after Intranasal Administration in Beagle Dogs
by: Jeong-Soo Kim, et al.
Published: (2018)

In vivo gastric residence and gastroprotective effect of floating gastroretentive tablet of DA-9601, an extract of Artemisia asiatica, in beagle dogs
by: Kim JS, et al.
Published: (2016)

Protective Effect of UP446 on Ligature-Induced Periodontitis in Beagle Dogs
by: Mesfin Yimam, et al.
Published: (2019)

Efficacy of Local Minocycline Agents in Treating Peri-Implantitis: An Experimental In Vivo Study in Beagle Dogs
by: Sung-Wook Yoon, et al.
Published: (2020)

Improved Manufacturability and In Vivo Comparative Pharmacokinetics of Dapagliflozin Cocrystals in Beagle Dogs and Human Volunteers
by: Sangho Cho, et al.
Published: (2021)

Study of single dose toxic test of Sweet Bee Venom in Beagle Dogs
by: Hye-Chul, Yoon, et al.
Published: (2010)

Effects of Sweet Bee Venom on cardiovascular system in the conscious telemetered Beagle Dogs
by: Lim Chung-San, et al.
Published: (2010)

Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions
by: Ying Ding, et al.
Published: (2023)

Geometry-Driven Fabrication of Mini-Tablets via 3D Printing: Correlating Release Kinetics with Polyhedral Shapes
by: Young-Jin Kim, et al.
Published: (2024)

Evaluation of Marbofloxacin in Beagle Dogs After Oral Dosing: Preclinical Safety Evaluation and Comparative Pharmacokinetics of Two Different Tablets
by: Zhixin Lei, et al.
Published: (2018)

Corrigendum: Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions
by: Ying Ding, et al.
Published: (2023)

Novel Herbal Therapeutic YH23537 Improves Clinical Parameters in Ligature-Induced Periodontal Disease Model in Beagle Dogs
by: Jang-Woo Shin, et al.
Published: (2023)

Corrigendum: Evaluation of Marbofloxacin in Beagle Dogs After Oral Dosing: Preclinical Safety Evaluation and Comparative Pharmacokinetics of Two Different Tablets
by: Zhixin Lei, et al.
Published: (2018)

Study of four week repeated dose toxic test of Sweet Bee Venom in Beagle Dogs
by: Jae-Seuk Park, et al.
Published: (2010)

Safety Assessment of Acer tegmentosum Maxim. Water Extract: General Toxicity Studies in Sprague-Dawley Rats and Beagle Dogs With Re-evaluation of Genotoxic Potentials
by: Jin-Sung Park, et al.
Published: (2021)

Pharmacokinetics of propafenone hydrochloride sustained-release capsules in male beagle dogs
by: Liping Pan, et al.
Published: (2015)

Toxicity Study of 28-Day Subcutaneous Injection of Arctigenin in Beagle Dogs
by: Jie Li, et al.
Published: (2019)

Evaluation of pharmacokinetics underlies the collaborated usage of lamivudine and oxymatrine in beagle dogs
by: Zhenbao Li, et al.
Published: (2016)

Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects
by: Kim HC, et al.
Published: (2023)

Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats
by: Tae Hwan Kim, et al.
Published: (2018)

Microcirculation changes in gingival tissue after ultrasonic tooth preparation in beagle dogs
by: Masahiro TO, et al.
Published: (2020)

Pharmacokinetic evaluation of Shenfu Injection in beagle dogs after intravenous drip administration
by: Yuqiao Zhang, et al.
Published: (2016)

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
by: Lan-hong Ruan, et al.
Published: (2021)

In vitro/vivo assessment of praziquantel nanocrystals: Formulation, characterization, and pharmacokinetics in beagle dogs
by: Ruyi Yang, et al.
Published: (2019)

Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole
by: Bae S, et al.
Published: (2021)

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers
by: Choi YJ, et al.
Published: (2015)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique
by: Wang H, et al.
Published: (2021)

Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs
by: Yuanyuan Meng, et al.
Published: (2022)

Evaluation of biomaterials with and without platelet-rich plasma: a histometric study using beagle dogs
by: Brunamelia Oliveira, et al.
Published: (2016)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique [Corrigendum]
by: Wang H, et al.
Published: (2023)

Herb-drug interactions of silybinin and cilofexor in beagle dogs based on pharmacokinetics by UPLC-MS/MS
by: Xinyi Wei, et al.
Published: (2024)

Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration
by: Ru Feng, et al.
Published: (2018)

Evaluation of pharmacokinetics and relative bioavailability of pentoxifylline and its metabolite in beagle dogs following different formulations
by: Yuxiang Xu, et al.
Published: (2024)

Multi-omics insights into beagle dog fed with a sucking-rewarded automatic feeding device
by: Yang Jiao, et al.
Published: (2024)

Antidiabetic and Hypolipidemic Effects of a Novel Dual Peroxisome Proliferator-Activated Receptor (PPAR) α/γ Agonist, E3030, in db/db Mice and Beagle Dogs
by: Shunji Kasai, et al.
Published: (2008)

Bone remodeling at microscrew interface near extraction site in the beagle dog mandible-histologic and immunohistochemical analyses
by: Guangxi Wei, et al.
Published: (2013)

Improved accuracy of digital implant impressions with newly designed scan bodies: an in vivo evaluation in beagle dogs
by: Ruoxuan Huang, et al.
Published: (2021)

Changes of electrocardiogram and hemodynamics in response to dipyridamole: In vivo comparative analyses using anesthetized beagle dogs and microminipigs
by: Kentaro Ando, et al.
Published: (2018)

Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study
by: Wang MJ, et al.
Published: (2021)

Pharmacokinetics and metabolism of cyadox and its main metabolites in beagle dogs following oral, intramuscular and intravenous administration
by: Adeel Sattar, et al.
Published: (2016)